Literature DB >> 27120802

Association of Psoriasis With the Risk for Type 2 Diabetes Mellitus and Obesity.

Ann Sophie Lønnberg1, Lone Skov1, Axel Skytthe2, Kirsten Ohm Kyvik3, Ole Birger Pedersen4, Simon Francis Thomsen5.   

Abstract

IMPORTANCE: Psoriasis has been shown to be associated with overweight and type 2 diabetes mellitus. The genetic association is unclear.
OBJECTIVE: To examine the association among psoriasis, type 2 diabetes mellitus, and body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) in twins. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional, population-based twin study included 34 781 Danish twins, 20 to 71 years of age. Data from a questionnaire on psoriasis was validated against hospital discharge diagnoses of psoriasis and compared with hospital discharge diagnoses of type 2 diabetes mellitus and self-reported BMI. Data were collected in the spring of 2002. Data were analyzed from January 1 to October 31, 2014. MAIN OUTCOMES AND MEASURES: Crude and adjusted odds ratios (ORs) were calculated for psoriasis in relation to type 2 diabetes mellitus, increasing BMI, and obesity in the whole population of twins and in 449 psoriasis-discordant twins. Variance component analysis was used to measure genetic and nongenetic effects on the associations.
RESULTS: Among the 34 781 questionnaire respondents, 33 588 with complete data were included in the study (15 443 men [46.0%]; 18 145 women [54.0%]; mean [SD] age, 44.5 [7.6] years). After multivariable adjustment, a significant association was found between psoriasis and type 2 diabetes mellitus (odds ratio [OR], 1.53; 95% CI, 1.03-2.27; P = .04) and between psoriasis and increasing BMI (OR, 1.81; 95% CI, 1.28-2.55; P = .001 in individuals with a BMI>35.0). Among psoriasis-discordant twin pairs, the association between psoriasis and obesity was diluted in monozygotic twins (OR, 1.43; 95% CI, 0.50-4.07; P = .50) relative to dizygotic twins (OR, 2.13; 95% CI, 1.03-4.39; P = .04). Variance decomposition showed that additive genetic factors accounted for 68% (95% CI, 60%-75%) of the variance in the susceptibility to psoriasis, for 73% (95% CI, 58%-83%) of the variance in susceptibility to type 2 diabetes mellitus, and for 74% (95% CI, 72%-76%) of the variance in BMI. The genetic correlation between psoriasis and type 2 diabetes mellitus was 0.13 (-0.06 to 0.31; P = .17); between psoriasis and BMI, 0.12 (0.08 to 0.19; P < .001). The environmental correlation between psoriasis and type 2 diabetes mellitus was 0.10 (-0.71 to 0.17; P = .63); between psoriasis and BMI, -0.05 (-0.14 to 0.04; P = .44). CONCLUSIONS AND RELEVANCE: This study determines the contribution of genetic and environmental factors to the interaction between obesity, type 2 diabetes mellitus, and psoriasis. Psoriasis, type 2 diabetes mellitus, and obesity are also strongly associated in adults after taking key confounding factors, such as sex, age, and smoking, into account. Results indicate a common genetic etiology for psoriasis and obesity.

Entities:  

Mesh:

Year:  2016        PMID: 27120802     DOI: 10.1001/jamadermatol.2015.6262

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  31 in total

Review 1.  Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

Review 2.  "Inflammatory skin march" in atopic dermatitis and psoriasis.

Authors:  Masutaka Furue; Takafumi Kadono
Journal:  Inflamm Res       Date:  2017-06-15       Impact factor: 4.575

3.  Association of Psoriasis With Comorbidity Development in Children With Psoriasis.

Authors:  Megha M Tollefson; Holly K Van Houten; Dennis Asante; Xiaoxi Yao; Hilal Maradit Kremers
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

4.  Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea.

Authors:  Dong Hyo Kim; Jin Yong Lee; Soo Ick Cho; Seong Jin Jo
Journal:  JAMA Dermatol       Date:  2022-06-01       Impact factor: 11.816

5.  Psoriasis: a brief overview.

Authors:  Antony Raharja; Satveer K Mahil; Jonathan N Barker
Journal:  Clin Med (Lond)       Date:  2021-05       Impact factor: 2.659

Review 6.  Cardiovascular disease prevention in individuals with underlying chronic inflammatory disease.

Authors:  Brittany Weber; Katherine P Liao; Marcelo DiCarli; Ron Blankstein
Journal:  Curr Opin Cardiol       Date:  2021-09-01       Impact factor: 2.108

7.  Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization.

Authors:  Micah Belzberg; Martin Prince Alphonse; Isabelle Brown; Kyle A Williams; Raveena Khanna; Byron Ho; Shannon Wongvibulsin; Thomas Pritchard; Youkyung Sophie Roh; Nishadh Sutaria; Justin Choi; Jaroslaw Jedrych; Andrew D Johnston; Kakali Sarkar; Chirag Vasavda; Jimmy Meixiong; Carly Dillen; Kent Bondesgaard; John F Paolini; Wei Chen; David Corcoran; Nicolas Devos; Madan M Kwatra; Anna L Chien; Nathan K Archer; Luis A Garza; Xinzhong Dong; Sewon Kang; Shawn G Kwatra
Journal:  J Invest Dermatol       Date:  2021-03-23       Impact factor: 7.590

8.  Gut Microbiota Dysbiosis and Altered Bile Acid Catabolism Lead to Metabolic Disorder in Psoriasis Mice.

Authors:  Yan Hao; Pei Zhou; Ya-Juan Zhu; Song Zou; Qixiang Zhao; Jiadong Yu; Yawen Hu; Jiong Li
Journal:  Front Microbiol       Date:  2022-04-14       Impact factor: 5.640

9.  Association of Metabolic Comorbidities with Pediatric Psoriasis: A Systematic Review and Meta-Analysis.

Authors:  Soo Ick Cho; Ye Eun Kim; Seong Jin Jo
Journal:  Ann Dermatol       Date:  2021-05-04       Impact factor: 1.444

Review 10.  Psoriasis and Genetics.

Authors:  Nick Dand; Satveer K Mahil; Francesca Capon; Catherine H Smith; Michael A Simpson; Jonathan N Barker
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.